ARTICLE | Company News
Aphios, ITC in HCV deal
June 20, 2001 7:00 AM UTC
Aphios (Woburn, Mass.) and ITC/Immune Technology will collaborate worldwide to develop, manufacture and market a natural therapeutic for chronic hepatitis C virus. R&D costs and sales revenues will be...